HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous lipopolysaccharide-induced pulmonary maturation and structural changes in fetal sheep.

AbstractBACKGROUND:
Antenatal pulmonary inflammation is associated with reduced risk for respiratory distress syndrome but with an increased risk for bronchopulmonary dysplasia (BPD) with impaired alveogenesis.
OBJECTIVE:
We hypothesized that fetal systemic inflammation induced by intravenous (IV) lipopolysaccharide (LPS) would affect lung development in utero.
STUDY DESIGN:
Twenty-one fetal sheep were instrumented (107 days gestational age). Control fetuses received saline (N = 12) and 9 in the study group received 100 ng of LPS IV 3 days after surgery. Animals were assessed for lung maturation and structure after 3 (N = 5) and 7 (N = 4) days.
RESULTS:
Interleukin-6 concentration increased in the bronchoalveolar lavage more than 40-fold 3 days after LPS IV. Processing of pro-surfactant protein (SP)-B to mature SP-B and increased SP-B concentrations were shown 7 days after LPS IV. Deposition of elastin fibers at sites of septation was disturbed within 3 days after LPS IV.
CONCLUSION:
Lung maturation and disturbed lung structure occurred after short-term exposure to fetal inflammation and suggests new targeted therapies for BPD.
AuthorsBoris W Kramer, Andreas Ladenburger, Steffen Kunzmann, Christian P Speer, Jasper V Been, J Freek van Iwaarden, Luc J I Zimmermann, Markus Gantert, Yves Garnier
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 200 Issue 2 Pg. 195.e1-10 (Feb 2009) ISSN: 1097-6868 [Electronic] United States
PMID19110233 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lipopolysaccharides
  • Pulmonary Surfactant-Associated Protein B
  • Elastin
Topics
  • Animals
  • Cell Proliferation
  • Elastin (immunology)
  • Female
  • Fetal Diseases (immunology)
  • Fetal Organ Maturity (immunology)
  • Fetus
  • Lipopolysaccharides (administration & dosage)
  • Lung (growth & development, immunology)
  • Lung Compliance
  • Lung Diseases (immunology)
  • Pulmonary Surfactant-Associated Protein B (immunology)
  • Sheep

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: